Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
140 participants
INTERVENTIONAL
2025-03-20
2025-05-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Pharmacist's intervention aims to answer:
1. How a pharmacist intervention program impact medication adherence in persistent asthma?
2. To assess how pharmacist led educational intervention like patients' counseling and medication reminders through Telemedicine have an impact on patient's asthma control?
3. Which mode of communication (Verbal instructions, videos and pamphlets) for the patient counselling is most beneficial for the patients in asthma control.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Pharmacist Interventions in Difficult Asthma
NCT02363192
The Impact of Clinical Pharmacist Intervention on Asthmatic Patient's Outcomes
NCT05933369
Medication Adherence and Use of Inhaler Devices in Patients With Asthma or COPD
NCT06417931
Telemedicine Education for Caregivers and Asthma Control in Children
NCT06753214
Effect of a Pharmaceutical Intervention on the Level of Control of the Asthmatic Patient
NCT01085474
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Pre-validated questionnaires will be used for the assessment
1. The adherence to asthma medication questionnaire (AAMQ-13).
2. Asthma Control test TM (ACT).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
intervention included the usual counselling by pharmacist e.g. Patients Education regarding Medications
* Pharmacist counseling patients regarding their disease and severity
* Pharmacist counseling (5- to 10-minute sessions) on the proper and safe use of medication.
* Pharmacist counseling patients regarding the importance of their therapy (treatment), non-pharmacological treatment like diet and exercises.
pharmacist counselling regarding the preventive measures that prevent patient from triggers that can initiate asthmatic attacks.
Educational
intervention included the usual counselling by pharmacist e.g. Patients Education regarding Medications
* Pharmacist counseling patients regarding their disease and severity
* Pharmacist counseling (5- to 10-minute sessions) on the proper and safe use of medication.
* Pharmacist counseling patients regarding the importance of their therapy (treatment), non-pharmacological treatment like diet and exercises.
pharmacist counselling regarding the preventive measures that prevent patient from triggers that can initiate asthmatic attacks.
Control group
No intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Educational
intervention included the usual counselling by pharmacist e.g. Patients Education regarding Medications
* Pharmacist counseling patients regarding their disease and severity
* Pharmacist counseling (5- to 10-minute sessions) on the proper and safe use of medication.
* Pharmacist counseling patients regarding the importance of their therapy (treatment), non-pharmacological treatment like diet and exercises.
pharmacist counselling regarding the preventive measures that prevent patient from triggers that can initiate asthmatic attacks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Persistent Asthma Patient.
* Patients taking medications and inhaler.
* Patient who will consent for the study.
* Patient with basic telecommunication facility.
* Patient who responded to messages and calls.
Exclusion Criteria
* Irresponsive patients to messages and calls
11 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hamdard University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Muhammad Abubakar
Assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hamdard University
Islamabad, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ABJan012025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.